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Background: There is some evidence which suggests that areca nut chewing has a relationship with metabolic
syndrome. Areca nut chewing is continue to increase and so is the metabolic syndrome which is a major cause of
cardiovascular mortality in developing countries. The aim of this study was to determine the relationship of raw
areca nut and areca nut chewing with tobacco additives and metabolic syndrome.
Methods: This cross sectional study was conducted on population of Karachi, Pakistan. Simple random sampling
was implied using the voter list as a sampling frame. A detailed questionnaire about the demographic details of all
subjects was filled and an informed consent obtained for blood sampling. Logistic regression analyses were carried
out to investigate the relationship between areca nut chewing and metabolic syndrome.
Results: Of the 1070 individuals, 192(17.9%) had metabolic syndrome with significantly higher (p-value <0.001)
prevalence among females (26.3%) compared with males (11.4%). Eight individuals (11.1%) among non users had
metabolic syndrome while significantly higher (p-value <0.001) proportion of both, raw areca nut users (n = 67,
29%) and areca users with tobacco additives (n = 45, 38.5%) had metabolic syndrome.
The crude odds ratio for central obesity among raw areca nut users was 1.46 (95% CI 1.07-1.98) and among areca
nut users with tobacco additives was 2.02 (95% CI 1.36-3.00), hypertension among raw areca nut users group was
1.31(0.96-1.78) and among areca nut users with tobacco additives group was 2.05 (95% CI 1.38-3.04). A significant
positive association of raw areca nut chewing and metabolic syndrome was found among males (crude OR 2.74,
95% CI 1.52-4.95) and females (crude OR 3.80, 95% CI 2.32-6.20). Similarly, a significant positive association was
found with regard to raw areca nut with tobacco additives chewing among males (crude OR 5.46, 95% CI 2.73-
10.91) and females (crude OR 4.32, 95% CI 2.41-7.72). These associations remained significant adjustment for age,
social class.
Conclusions: This study suggests a harmful relationship between areca nut chewing and metabolic syndrome. The
deleterious effects were even stronger among areca nut chewer with tobacco additives. Further research with
longitudinal data might help to understand the temporal relationship between areca nut chewing and metabolic
syndrome.
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The metabolic syndrome has become one of the major
public-health challenges worldwide [1]. The metabolic
syndrome is defined as a cluster of dangerous risk
factors (particularly for heart disease), which include
diabetes, pre-diabetes (raised blood glucose level), ab-
dominal obesity, high cholesterol level and high blood
pressure [1]. There has been growing interest in this
group of closely related cardiovascular risk factors
because this group is at significantly higher risk of devel-
oping both cardiovascular and cerebrovascular diseases.
Areca nut chewing has been recently linked with
metabolic syndrome [2]. Approximately 600 million in-
dividuals chew Areca nut worldwide making it fourth
commonest substance after nicotine, ethanol and caf-
feine [3]. Areca nut chewing has already been linked
with the development of oral and oesophageal cancer,
hepatocellular carcinoma [4-6] and more recently with
metabolic syndrome [7-9].
Two earlier studies have suggested that areca nut
chewers are significantly more likely to have metabolic
syndrome with up to two-fold increase in risk compared
with non-users [10,11]. Furthermore, some other studies
have attempted to examine the relationship between
areca nut chewing and components of metabolic syn-
drome particularly obesity [12,13] and diabetes mellitus
[14,15]. Three studies reported increased risk of general
and central obesity among areca nut chewers compared
with non-users [11-13]. The increased risk reported in
these studies ranged from 30% to two-fold [11-13].
Additionally, two other studies reported 30% increase
odds of diabetes mellitus and hyperglycaemia among
areca nut users compared with non-users [14,15].
It is important to understand whether the relationship
between areca nut and metabolic syndrome remains
similar between different types of areca nuts [3,16]. Re-
cently, there is a trend of areca nut chewing with addi-
tives particularly nicotine - which may be worse than the
raw areca nuts. Therefore, it is important to examine the
effects of areca nut chewing (with and without additives)
on metabolic profiles of health individuals. There is no
previous evidence examining such effects of areca nut
chewing with tobacco additives and metabolic syndrome.
Therefore, the objective of this study is to determine
the relationship of areca nut chewing with or without
additives and metabolic syndrome.
Methods
This was a cross sectional study conducted in new
Karachi town, Karachi, Pakistan an area of approximate
population of 1 million. Individuals were selected through
simple random sampling from the sampling frame of voter
list. Sample was calculated using the WHO software for
sample size determination in health studies. Sample sizewas calculated based on proportion of prevalence of areca
nut chewing as reported by a previous study [3]. To calcu-
late sample size by using proportion of 28.9% at confidence
level of 95% and bound of error 3%, the estimated sample
size required was 1475. Total 1500 individuals were
recruited for participation in the study. Participants were
included between the ages of 16 to 75 years of age. Pre-
tested self administered questionnaire which included
socio-demographic details, lifestyle habits and history
of any known chronic disease, current and past use of
medications. A trained data collector was hired, he
collected the data and serum blood samples were
drawn and sent to laboratory for carrying out blood
biochemical and haematological investigations.
International Diabetic Federation (IDF) values were
used for central obesity, raised triglyceride, reduced
HDL, raised BP and Hyperglycaemia [17]. According to
the new definition for a person to be defined as having
the metabolic syndrome must have central obesity plus
any two of the four factors which include raised
triglyceride (TG) (≥1.7 mmol/L or specific treatment for
this lipid abnormality), reduced High Density Lipopro-
tein (HDL) cholesterol (<1.03 mmol/L in males and
<1.29 mmol/L in females or specific treatment for this
lipid abnormality), raised blood pressure (systolic blood
pressure ≥130 or diastolic blood pressure ≥85 or treat-
ment of previously diagnosed hypertension) and raised
fasting plasma glucose (≥5.6 mmol/L or previously diag-
nosed type 2 diabetes) [17]. To determine the abdominal
obesity we used South Asian specific cut off in which a
waist circumference for male ≥ 90 cm and female ≥80
was considered as obese [17]. Ethical approval was given
by an independent ethics committee at Afra General
Hospital, Faisalabad, Pakistan. Consent form and ques-
tionnaire was developed in English and Urdu to dissem-
inate the objectives of this research study to the
participants and written consent was obtained prior to
interview.
Investigations
Blood samples were taken to investigate complete blood
count, lipid profile and blood glucose. Used Sysmex
Pouch counter (An automated machine by S Ejaz uddin
& co) for complete blood count. For complete blood
count, we took 5 ml of blood in a purple top vaccutainer
(containing ethylene diamine tetra acetic acid in it in it)
and after 5 min mixing on rotator, the sample was ran in
machine and results were obtained.
Statistical analysis
Stata software version 11 (StataCorp, College Station,
TX, USA) were used to analyse the collected data. Par-
ticipants were divided into three categories based on
their areca nut chewing habits, i.e. non users, raw areca
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obesity was diagnosed by using the waist circumference
measurements and ethnicity specific values cut offs [17].
Mean and standard deviation were calculated for con-
tinuous variables and frequency for categorical variables.
Univariate and multivariate logistic regression were used
to estimate crude and adjusted odds ratio for metabolic
syndrome using demographic and areca nut chewing
co-variates. We also compared the gender differences in
existence of metabolic syndrome and its components.
Age-stratified analysis was also carried out to examine
the relationship between areca nut chewing and meta-
bolic syndrome. All the significance tests were two tailed
with a significance level 0.05%.
Results
Basic characteristics of study sample
In total, 1500 individuals were invited for this study,
1089 accepted the invitation (response rate 72.6%).
Nineteen individuals were not eligible due to current fe-
brile illness while areca nut chewing, haematological and
biochemistry data were missing for 10 individuals so the
final analysis included the data of 1070 apparently
healthy individuals. Of the 1070, 348 (32.5%) were areca
nut users. Among these 348, 117 (33.6%) were users ofTable 1 Baseline characteristics of study sample based on are
Characteristics Non-users
Raw
Total participants, n(%) 722(67.5)
Male sex, n(%) 419(70.0)
Age, mean (SD) 33.8(15.3)
Age, n(%)
Age 16-39 470(67.3)
Age 40-49 99(66.9)
Age 50-59 87(69.1)
Age 60-75 66(67.4)
Waist circumference, mean(SD) 80.3(12.1)
Central obesity, n(%) 231(32.0)
Systolic blood pressure, mm Hg, mean(SD) 123.6(19.0)
Diastolic blood pressure, mm Hg, mean(SD) 71.6(9.5)
Cholesterol level, mmol/L, mean(SD) 5.6(1.1)
High density lipoprotein, mmol/L, mean(SD) 1.4(0.4)
Serum triglyceride level, mmol/L, mean(SD) 1.4(0.9)
Blood glucose level, mmol/L, mean(SD) 4.8(0.9)
Social class
Professionals 158(67.5)
Non-manual workers 115(42.3)
Manual workers 449(79.6)
*p-value for categorical variables was calculated by chi squared test and with ANOVareca nut with tobacco additives. Males were slightly
more likely to be non-users and female were slightly
more likely to be areca nut users with tobacco additives
(p-value 0.05). Generally, there were no significant
differences in age between three groups (p-value 0.95)
and total cholesterol level (p-value 0.31). Areca nut users
with tobacco additives had significantly, higher waist cir-
cumference (p-value <0.001), higher systolic (p-value
<0.001) and diastolic blood pressure (p-value 0.003),
higher blood glucose level (p-value <0.001), higher
serum triglyceride level (p-value 0.004) and lower high
density lipoprotein (p-value 0.03). Basic characteristics
of study sample have been summarized in Table 1.
Areca nut chewing and metabolic syndrome
Of the 1070 individuals, 192 (17.9%) had metabolic syn-
drome with significantly higher (p-value <0.001) preva-
lence among females (26.3%) compared with males
(11.4%). Eight individuals (11.1%) among non users had
metabolic syndrome while significantly higher (p-value
<0.001) proportion of both, raw areca nut users (n = 67,
29%) and areca users with tobacco additives (n = 45,
38.5%) had metabolic syndrome. Age-adjusted preva-
lence of metabolic syndrome significantly differed be-
tween male and female areca nut users. A significantca nut chewing categories
Areca nut chewers
P-value*
areca nut users Areca with tobacco additives
231(21.6) 117(10.9) _
126(21.0) 54(9.0) 0.05
33.9(15.6) 33.4(14.7) 0.95
151(21.6) 77(11.0) 0.95
32(21.6) 17(11.5)
24(19.1) 15(11.9)
24(24.5) 8(8.2)
82.1(12.4) 84.0(12.3) 0.003
94(40.7) 57(48.7) <0.001
126.5(20.4) 131.0(21.4) <0.001
73.1(9.8) 74.5(9.6) 0.003
5.8(1.2) 5.7(1.0) 0.31
1.3(0.4) 1.3(0.4) 0.03
1.6(1.1) 1.6(1.0) 0.004
5.0(1.2) 5.3(2.0) <0.001
44(18.8) 32(13.7) <0.001
113(41.5) 44(16.2)
74(13.1) 41(7.3)
A for continuous variables.
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nut chewing among males (crude OR 2.74, 95% CI 1.52-
4.95) and females (crude OR 3.80, 95% CI 2.32-6.20).
Similarly, a significant positive association was found
with regard to raw areca nut with tobacco additives
chewing among males (crude OR 5.46, 95% CI 2.73-
10.91) and females (crude OR 4.32, 95% CI 2.41-7.72).
These associations remained significant adjustment for
age, social class (Table 2).
We also conducted age stratified analysis to examine
the relationship between areca nut chewing and meta-
bolic syndrome. Among those age <40 years, areca nut
chewers were 4.3 time more likely to have metabolic
syndrome (OR 4.30, 95% CI 2.74-6.74) after adjusting
for social class, compared to non-chewers. Likewise,
those age ≥40 years, areca nut chewers were four times
more likely to have metabolic syndrome (OR 4.03, 95%
CI 2.74-6.74), after accounting for social class, compared
to non-chewers.
Areca nut chewing and components of metabolic
syndrome
The crude odds ratio for central obesity among raw
areca nut users was 1.46 (95% CI 1.07-1.98) and among
areca nut users with tobacco additives was 2.02 (95% CI
1.36-3.00 p-value for trend <0.001). This association
slightly attenuated but remained significant (p-value for
trend 0.02) after adjustment for age, gender and social
class. The crude odds ratio for hypertension among raw
areca nut users group was 1.31 (0.96-1.78) and among
areca nut users with tobacco additives group was 2.05
(95% CI 1.38-3.04, p-value for trend <0.001) while the
odds ratio after controlling for possible confounding was
1.23 (95% CI 0.89-1.70) and 1.87 (95% CI 1.25-2.81,
p-value 0.003), respectively. Similarly, raw areca nut
users had significantly, reduced HDL (OR 1.72, 95% CI
1.72-2.33), hypertriglyceridemia (OR 1.73, 95% CI 1.24-
2.41) and hyperglycemia (OR 1.65, 95% CI 1.11-2.46).
These associations remained significant after controlling
for age, gender and social class (Table 3). The pattern ofTable 2 The relationship between areca nut chewing and met
Metabolic syndrome
Males
Univariate
analysis P-value
Multivariate
analysis *
OR (95% CI) OR (95% CI)
Areca nut chewing
Non users Reference Reference
Raw areca nut
chewers
2.74 (1.52-4.95) 0.001 2.85 (1.47-5.53)
Areca nut with
tobacco additives
5.46 (2.73-10.91) <0.001 5.41 (2.49-11.74)
*Multivariate models included age and social class.associations of metabolic syndrome remains similar
among areca nut users with tobacco additives and even
higher odds ratio compared to raw areca nut chewers
(Table 3).
Discussion
The present study suggests that areca nut chewing has
significant relationship with metabolic syndrome. It was
notable that areca nut chewers with tobacco additives
had higher odds of metabolic syndrome compared with
raw areca users. Furthermore, areca nut chewing was
associated with increased odds of central obesity, hyper-
tension, hyperglycemia and dyslipidemia. These relation-
ships remain unchanged even after adjusting for age,
gender and social class. This study also highlighted that
areca nut chewing may have differential effects on
metabolic syndrome and its component with more
deleterious effects among females.
The findings of this study are consistent in terms of
direction of association that areca nut chewers are more
likely to have metabolic syndrome, however the effect
sizes – both for metabolic syndrome and components of
metabolic syndrome - reported in this study are gener-
ally greater than the earlier studies [10,11]. The odds of
having obesity and diabetes mellitus among areca nut
users are also significantly higher in our study compared
with earlier studies, where some examined obesity
[11-13] and others examined diabetes mellitus [14,15].
Although the underlying mechanism of these associa-
tions remains unclear, however, several possible path-
ways have been suggested earlier. The suppression of
hunger reported by some long term areca nut chewers
may induce a state of malnutrition which could lead to-
wards vitamin-D deficiency [18]. Vitamin-D has been
identified as risk factor for many systemic disease in-
cluding MetS and diabetes mellitus [19]. In an experi-
mental study, young adult CD1 mice were fed areca nut
in standard feed for 2–6 days. On comparison with con-
trols, these mice had significantly higher incidence of
diabetes mellitus at the age of six months [20,21]. Aabolic syndrome by gender
Metabolic syndrome
Females
P-value
Univariate
analysis P-value
Multivariate
analysis * P-value
OR (95% CI) OR (95% CI)
Reference Reference
0.002 3.80 (2.32-6.20) <0.001 4.22 (2.40-7.41) <0.001
<0.001 4.32 (2.41-7.72) <0.001 4.37 (2.31-8.26) <0.001
Table 3 Relationship between areca nut chewing and components of metabolic syndrome
Non chewers Raw areca chewers
Areca nut chewers
P-value for trend
Areca with tobacco additives
Total participants 722 231 117
Central Obesity
Obese, n(%) 231 (32.0) 94 (40.7) 57 (48.7)
Odds Ratio (95% CI)a reference 1.46 (1.07-1.98) 2.02 (1.36-3.00) <0.001
Odds Ratio (95% CI)b reference 1.42 (0.97-2.06) 1.65 (1.03-2.63) 0.015
Raised blood pressure
Raised BP cases, n(%) 234 (32.4) 89 (38.5) 58 (49.6)
Odds Ratio (95% CI)a reference 1.31 (0.96-1.78) 2.05 (1.38-3.04) <0.001
Odds Ratio (95% CI)b reference 1.23 (0.89-1.70) 1.87 (1.25-2.81) 0.003
Reduced HDL
Reduced HDL cases, n(%) 233 (32.8) 104 (45.0) 58 (50.0)
Odds Ratio (95% CI)a reference 1.72 (1.27-2.33) 2.06 (1.39-3.06) <0.001
Odds Ratio (95% CI)b reference 1.55 (1.11-2.17) 1.66 (1.09-2.54) 0.003
Hypertrigylceridemia
Hypertriglyceridemia cases, n(%) 150 (20.8) 72 (31.2) 41 (35.0)
Odds Ratio (95% CI)a reference 1.73 (1.24-2.41) 2.06 (1.35-3.13) <0.001
Odds Ratio (95% CI)b reference 1.82 (1.28-2.59) 2.04 (1.32-3.16) <0.001
Hyperglycemia
Hyperglycemia cases, n(%) 88 (12.2) 43 (18.6) 26 (22.2)
Odds Ratio (95% CI)a reference 1.65 (1.11-2.46) 2.06 (1.26-3.36) 0.001
Odds Ratio (95% CI)b reference 1.48 (0.97-2.27) 1.80 (1.08-3.00) 0.011
a = unadjusted odds ratio, b = estimates adjusted for age, gender and social class.
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nut chewing and obesity which has been reported by
many population-based studies [22]. Arecoline (an alkal-
oid which is a major component of areca nuts) by inter-
fering with gamma-aminobutyric acid receptors, can
suppress the appetite while increasing postprandial
carbohydrate use [23].
Interestingly, the effect sizes for metabolic syndrome
and its components observed in this study for raw areca
nut chewers are fairly consistent as reported earlier.
However, areca nut chewers with tobacco additives were
significantly more likely to have metabolic syndrome.
There is no earlier study which reported on type of areca
and its relationship with metabolic syndrome so we are
unable to compare these estimates with any known
figures. However, it is reasonable to assume that tobacco
content of these nuts may be mediating some additional
metabolic changes leading to metabolic syndrome.
The lifestyle factors, for instance, dietary habits and
physical activity, may also be contributing to the devel-
opment of metabolic syndrome. However, we further ad-
justed for social class of individuals which covers some
of these aspects of lifestyle but the apparent relationship
between areca nut chewing and metabolic syndromeremain unchanged. Simultaneously, the role of confounding
factors such as lower education and health risk behaviours,
which increase the risk of metabolic syndrome may also
have some effect on this relationship but as social class was
derived by occupation, any such effect may have been
accounted by adjusting for social class. However, we can
not completely rule out the possibility of some residual
confounding by lower education and health risk behaviour
on this relationship between areca nut chewing and meta-
bolic syndrome.
Strength and limitations
This is the first study which examined the role of differ-
ent types of areca nuts on metabolic syndrome and its
components. Most previous studies only included male
subjects while this study also had a fairly large sample of
females which provides further insight to the differential
distribution of metabolic syndrome and its components
between males and females. There are few limitations of
this study which are worth to be reported. We aimed to
obtain a sample of 1475 individuals; however, the re-
quired sample size was not achieved. Although, this was
a limitation of this study, but the association between
areca nut chewing and metabolic syndrome remains
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that suggests a convincing association between areca nut
chewing and metabolic syndrome may be present, and a
larger study may provide more precise estimate for this
relationship. This study used cross sectional design,
which is not the best approach to examine any causal
relationships, however this study does raise some ques-
tions about the different types of areca nuts and its
relationship which needs further investigation. Future re-
search with prospective design may provide robust evi-
dence on role of areca nut chewing in development of
metabolic syndrome. Finally some element of bias can
not be excluded as individuals with higher consumption
of areca nut may have other systemic symptoms or re-
peated infections which may lead to higher utility of
health care services. However, random invitations might
have eliminated some of the effects caused by chance.
Conclusion
This study suggests a harmful relationship between areca
nut chewing and metabolic syndrome. The deleterious ef-
fects were even stronger among areca nut chewers with
tobacco additives. Further research with longitudinal
data might help to understand the temporal relationship
between areca nut chewing and metabolic syndrome.
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